Giant Cell Tumor of Tendon Sheath in Guyon's Canal Causing Ulnar Tunnel Syndrome

CASE REPORT

A 37-year old, right-hand dominant woman who works as a buyer of candy and tobacco for a wholesale distributor presented with decreased sensation and weakness of right-hand grip. Upon examination, a proximal hypothenar fullness was noted. At the time of presentation, the patient indicated that this fullness has waxed and waned for the past 1 year. Over the past 6 months the patient had increased numbness and tingling in the ulnar 2 digits and generalized weakness of her right hand. Ultrasound examination was performed and showed a solid heterogeneous mass of the hypothenar eminence. A follow-up magnetic resonance imaging (MRI) noted a 2.2 × 2.4 × 2-cm bi-lobed mass within the hypothenar musculature, which appeared to be displacing the ulnar artery and ulnar nerve (Fig 1). Based on this MRI a differential diagnosis of desmoid versus sarcoma was given by the radiologist. It was, therefore, determined that incisional or excisional biopsy of the mass would be the most appropriate course of treatment.

Figure 1. Sagittal T1-weighted magnetic resonance image of the right hand showing a giant cell tumor of tendon sheath involving the ulnar neurovascular bundle at Guyon's canal. The red arrow indicates the ulnar neurovascular bundle. The white arrow indicates the mass.

In the operating room under general anesthesia, a 5-cm Brunner's incision was made directly over Guyon's canal. It extended 3.5 cm distal and 1.5 cm proximal to the wrist crease. The mass was identified and was found to originate at the distal portion of Guyon's canal, extending distally into the hypothenar musculature. The mass was intertwined with the superficial and deep palmar branches of the ulnar nerve proximal to where the deep palmar branch of the ulnar nerve enters the hypothenar tunnel and was impinging upon the ulnar artery (Fig 2). Since the diagnosis was unclear, the hand was not forcefully exsanguinated and care was taken to not disrupt the fascial planes. A small portion of the mass was excised and sent as a frozen section to make the diagnosis. After careful dissection, the lesion was found to be loosely associated with the undersurface of the flexor carpi ulnaris tendon and more associated with the flexor retinaculum. Guyon's canal was released and careful neurolysis was performed. A 2.5-cm, well-circumscribed, bi-lobed mass was removed and sent for pathological evaluation, which indicated a GCTTS (Fig 3). Four months postoperatively, the patient had fully restored sensory and motor function of the right hand (Fig 4).

Figure 2. Operative view of the giant cell tumor of tendon sheath entangled in the ulnar nerve. The blue loop is holding the superficial branch of ulnar nerve. The white arrow indicates the ulnar artery. The black arrow indicates the ulnar nerve.

Figure 3. The removed mass.

Figure 4. The patient's hand postoperatively.

DISCUSSION

Jaffe et al¹³ first described GCTTS pathologically in 1941. They postulated that this lesion has a common histological origin with pigmented villonodular synovitis; the major difference being that GCTTS grows outward from the tendon sheath, whereas pigmented villonodular synovitis grows inward from the synovial lining into the joint. There are 3 main cell types that compose GCTTS; these are multinucleated, osteoclast-like giant cells, round or polygonal mononuclear cells, and histiocyte-like cells (foam cells).¹⁴ All of these cells contain hemosiderin in their cytoplasm.³ Gross observation shows lesions that can be yellow, brown, gray-white, and red. Yellowish lesions are laden with lipid, whereas a brown color indicates a predominance of iron. Yellow and brown lesions tend to be associated with GCTTS. The gray-white color indicates the presence of fibrous tissue. The red lesions are typically associated with diffuse pigmented villonodular synovitis.^14–16

While the precise origin of GCTTS is unknown, it has been associated with many different processes including inflammatory, reactive, neoplastic, traumatic, and immune mediated causes. However, based on evidence of DNA flow cytometry¹⁷, nm23 gene expression,¹⁸ and cytogenetic abnormalities¹⁹ there is growing evidence that these lesions arise from a neoplastic origin.

Giant cell tumor of tendon sheath can be localized or diffuse. Most often, localized GCCTS is well circumscribed by a thin, fibrous capsule and presents as a small (average, 1.1 cm), slow-growing mass that is firm to the touch, non-tender, and is most often found on tendon sheaths or in the joints of digits.^2–4 Diffuse GCTTS is most commonly associated with the knee and is much less common.⁴ Pigmented villonodular synovitis is identified by a diffusely proliferated synovial membrane with villous projections, may or may not have nodules, and most frequently involves the knee and hip joints. This lesion is usually large (average, 2 cm) and covered by one or more layers of synovial cells.^3,4

The most common benign masses of the hand are ganglion, GCTTS, epidermal inclusion cysts, hemangiomas, fibromas, mucous cysts, and lipomas.^20–24 Giant cell tumor of tendon sheath is the most common solid, soft-tissue lesion of the hand¹ and is the second most common mass of the hand, second to ganglion.^1,20,23 Typically, it is more common in women than men and the mean age of diagnosis is between 30 and 50 years.^1,15

To our knowledge, there have been only 5 case reports on GCTTS located at Guyon's canal in the English literature^6–8,10,11 and 1 in the non-English literature.⁹ Each case presented with ulnar tunnel syndrome symptoms. In all cases the lesion was impinging upon the ulnar neurovascular bundle in or around Guyon's canal, thereby producing symptoms of ulnar tunnel syndrome. Correct diagnosis was made only upon pathological evaluation.

The sites of ulnar nerve compression within Guyon's canal can be classified into 3 zones. Zone 1 is located distal to the bifurcation of the ulnar nerve into superficial and deep palmar branches. Compression of the ulnar nerve in zone 1 can produce complete sensory and motor deficits, purely sensory or purely motor deficits. Zone 2 surrounds the deep motor branch of ulnar nerve. Compression in zone 2 results in paralysis of the intrinsic muscles and may involve the hypothenar muscles depending upon where the compression occurs in zone 2. Zone 3 surrounds the superficial branch of ulnar nerve. Compression in zone 3 results in purely sensory deficits.^25,26

The most common method for treatment of GCTTS is surgical excision; however, the average recurrence rate is 26.5% (range, 9%–44%) with an average time of recurrence of 2 years 3 months (range, 3 months to 10 years).²⁷ Recurrence is common if the lesion is not completely removed. Other factors which increase the rate of recurrence include multiple primary lesions, tumors involving the thumb, and erosion of the bone.^18,23 In addition to excision of the lesion, release of Guyon's canal may be indicated to relieve nerve compression symptoms. The ulnar nerve bifurcates into superficial and deep palmar branches proximal to Guyon's canal. The deep palmar branch of the ulnar nerve continues distally through the hypothenar tunnel, the floor being formed by the piso-hamate ligament and the roof being formed by tendinous origin of a portion of the hypothenar muscles: the adductor digiti minimi, the flexor digiti minimi brevis, and the opponens digiti minimi muscles.²⁸ It is important to inspect the deep palmar branch as it travels in the hypothenar tunnel as it may require decompression if the lesion involves the nerve in this structure. Furthermore, once the lesion is removed, the surrounding area should be inspected for satellite lesions and if present these should be removed. If osseous erosion has occurred, removing that part of the cortical shell that has been involved may be indicated to prevent recurrence. Radiation may play a role in the treatment of GCTTS.¹⁴ However, given the complications of possible hand contracture, radiation is not currently utilized. With regard to more conservative treatment, GCTTS does not resolve on its own.¹⁴ Therefore, surgical intervention is the only current method of treatment to resolve and relieve symptoms.

Kitagawa et al²⁹ state that T1- and T2-weighted MR images of GCTTS located in the hand produce signal intensities between muscle and fat. In addition, they note that the relatively low signal intensity on T2-weighted images of GCTTS is an important feature that differentiates it from soft-tissue sarcoma, which usually has a signal intensity equal to or greater than that of fat on T2-weighted images. Nevertheless, Kittagawa et al speculate that these MRI findings may apply only to the hand. Other MRI studies that have assessed GCTTS included more lesions of the lower extremity, whereas the Kittagawa et al study was composed mainly of GCTTS of the hand (88%). To explain this, they include a finding from Rao and Vigorita¹⁶ that shows that lesions of the fingers have fewer iron deposits. Less iron serves to shorten the T2-relaxation time due to the magnetic susceptibility effect.¹⁶ With regard to MRI enhancement, De Beuckeleer et al³⁰ report that gadolinium administration enhances GCTTS due to proliferation of capillaries in the stroma. Moreover, Khan et al³¹ state that mild-to-moderate diffuse enhancement is helpful in distinguishing GCTTS from ganglion. Thus, gadolinium enhancement can play an important role in further refining the diagnosis.

SUMMARY

This case demonstrates that ulnar tunnel syndrome caused by GCTTS is a rare occurrence and that it is often misdiagnosed preoperatively. Since GCTTS is the most common solid, soft-tissue lesion of the hand, it should always be included in the differential diagnosis whenever a mass of the hand is presented. Regarding imaging, MRI with and without enhancement may be useful for diagnosis. Nevertheless, a definitive diagnosis can be provided only by pathologic evaluation. Surgical removal is the standard treatment of GCTTS and it is important that the entire lesion be removed. This is crucial to reduce chances of lesion recurrence. Lastly, release of Guyon's canal and the hypothenar tunnel may be indicated at the time of lesion excision to help relieve nerve compression symptoms.

This study was funded by the UTHSCSA Medical Dean's Office 2008 Summer Research Stipend.